Guminski, A., Squittieri, N. and Lear, J.T. 2020. Adverse Events of Special Interest in Patients with Advanced Basal Cell Carcinoma Receiving Sonidegib: Long-Term 42-Month Results from the BOLT Study. SKIN The Journal of Cutaneous Medicine. 4, 5 (Sep. 2020), s67. DOI:https://doi.org/10.25251/skin.4.supp.66.